Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 9/20 | 0.67 |
| ▸ | CNR1 | P21554 | 6/20 | 0.67 |
| ▸ | MEN1 | O00255 | 1/20 | 0.67 |
| ▸ | GAA | P10253 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.67 |
| ▸ | MAOA | P21397 | 2/20 | 0.34 |
| ▸ | MAOB | P27338 | 2/20 | 0.34 |
| ▸ | AKT1 | P31749 | 1/20 | 0.30 |
| ▸ | STAT3 | P40763 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31546045 | 0.90 | CNR2 (0.54) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL31544851 | 0.81 | CNR2 (1.00) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL31545774 | 0.81 | CNR2 (1.00) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL11639037 | 0.81 | CNR2 (1.00) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL31545563 | 0.79 | CNR2 (0.41) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL22783274 | 0.78 | CNR2 (0.78) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL706275 | 0.77 | CNR2 (0.55) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL11665838 | 0.74 | CNR2 (0.69) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL6972822 | 0.74 | CNR2 (0.67) | CNR2CNR1MEN1GAAKMT2A | |
| SCHEMBL16124349 | 0.74 | CNR2 (0.94) | CNR2CNR1MEN1GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |